Your browser doesn't support javascript.
loading
Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association-European Society of Cardiology.
Maack, Christoph; Lehrke, Michael; Backs, Johannes; Heinzel, Frank R; Hulot, Jean-Sebastien; Marx, Nikolaus; Paulus, Walter J; Rossignol, Patrick; Taegtmeyer, Heinrich; Bauersachs, Johann; Bayes-Genis, Antoni; Brutsaert, Dirk; Bugger, Heiko; Clarke, Kieran; Cosentino, Francesco; De Keulenaer, Gilles; Dei Cas, Alessandra; González, Arantxa; Huelsmann, Martin; Iaccarino, Guido; Lunde, Ida Gjervold; Lyon, Alexander R; Pollesello, Piero; Rena, Graham; Riksen, Niels P; Rosano, Giuseppe; Staels, Bart; van Laake, Linda W; Wanner, Christoph; Farmakis, Dimitrios; Filippatos, Gerasimos; Ruschitzka, Frank; Seferovic, Petar; de Boer, Rudolf A; Heymans, Stephane.
Afiliação
  • Maack C; Comprehensive Heart Failure Center, University Clinic Würzburg, Würzburg, Germany.
  • Lehrke M; Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany.
  • Backs J; Department of Molecular Cardiology and Epigenetics, University of Heidelberg, Heidelberg, Germany.
  • Heinzel FR; Department of Cardiology, Charité-Universitätsmedizin, Berlin, Germany.
  • Hulot JS; Paris Cardiovascular Research Center PARCC, INSERM UMR970, CIC 1418, and F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Paris, France.
  • Marx N; AP-HP, Hôpital Européen Georges-Pompidou, Paris, France.
  • Paulus WJ; Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany.
  • Rossignol P; Department of Physiology, VU University Medical Center, Amsterdam, The Netherlands.
  • Taegtmeyer H; Inserm, Centre d'Investigations Cliniques-Plurithématique 14-33, Inserm U1116, CHRU Nancy, Université de Lorraine, and F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France.
  • Bauersachs J; Department of Internal Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Bayes-Genis A; Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.
  • Brutsaert D; Heart Failure Unit and Cardiology Service, Hospital Universitari Germans Trias i Pujol, CIBERCV, Badalona, Spain.
  • Bugger H; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Clarke K; Prof-Emer, University of Antwerp, Antwerp, Belgium.
  • Cosentino F; Cardiology and Angiology, Heart Center, University of Freiburg, Freiburg, Germany.
  • De Keulenaer G; Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK.
  • Dei Cas A; Department of Medicine Solna, Cardiology Unit, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden.
  • González A; Laboratory of Physiopharmacology, University of Antwerp, Antwerp, Belgium.
  • Huelsmann M; Department of Medicine and Surgery, Endocrinology and Metabolism, University of Parma, Parma, Italy.
  • Iaccarino G; Division of Endocrinology and Metabolic Diseases, Azienda Ospedaliero-Universitaria of Parma, Parma, Italy.
  • Lunde IG; Program of Cardiovascular Diseases, Centre for Applied Medical Research, University of Navarra, Pamplona and CIBERCV, Carlos III Institute of Health, Madrid, Spain.
  • Lyon AR; Division of Cardiology, Department of Medicine II, Medical University of Vienna, Vienna, Austria.
  • Pollesello P; Department of Medicine, Surgery and Dentistry, University of Salerno, Baronissi, Italy.
  • Rena G; Institute for Experimental Medical Research, Oslo University Hospital and University of Oslo, Oslo, Norway.
  • Riksen NP; Cardiovascular Research Centre, Royal Brompton Hospital; National Heart and Lung Institute, Imperial College London, London, UK.
  • Rosano G; Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Staels B; Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK.
  • van Laake LW; Department of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Wanner C; Cardiovascular Clinical Academic Group, St George's Hospitals NHS Trust University of London, London, UK.
  • Farmakis D; IRCCS San Raffaele Roma, Rome, Italy.
  • Filippatos G; University of Lille-EGID, Lille, France.
  • Ruschitzka F; Inserm, U1011, Lille, France.
  • Seferovic P; Institut Pasteur de Lille, Lille, France.
  • de Boer RA; University Hospital CHU Lille, Lille, France.
  • Heymans S; Department of Cardiology, Heart and Lungs Division, and Regenerative Medicine Centre, University Medical Centre Utrecht, Utrecht, the Netherlands.
Eur Heart J ; 39(48): 4243-4254, 2018 12 21.
Article em En | MEDLINE | ID: mdl-30295797
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sociedades Médicas / Diabetes Mellitus / Pesquisa Translacional Biomédica / Insuficiência Cardíaca Tipo de estudo: Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Eur Heart J Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sociedades Médicas / Diabetes Mellitus / Pesquisa Translacional Biomédica / Insuficiência Cardíaca Tipo de estudo: Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Eur Heart J Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Alemanha